文献速递免疫规划

马来布鲁丝虫重组钙调蛋白:二级结构与免疫预防潜力

Recombinant Calponin of human filariid Brugia malayi: Secondary structure and immunoprophylactic potential.
PubMed 文献 · Vaccine · 2017-08-05

本研究克隆、表达并表征了马来布鲁丝虫重组钙调蛋白(r-ClpBm),其为约45kDa的α-螺旋蛋白,与盘尾丝虫OV9M同源,在虫体各生活史阶段均有表达。用r-ClpBm免疫Mastomys coucha后,寄生虫负荷抑制约42%,伴随细胞增殖、TNF-α、IFN-γ、IL-1β、IL-4、NO释放、iNOS表达及特异性IgG、IgG1、IgG2b上调,多数肥大细胞脱颗粒。作者认为r-ClpBm可进一步与其他保护性分子联合研究,作为潜在丝虫鸡尾酒疫苗候选组分之一。

要点

  • r-ClpBm为约45kDa的α-螺旋蛋白,与盘尾丝虫OV9M同源,在微丝蚴、L3、L4、L5及成虫各阶段均表达。
  • r-ClpBm免疫Mastomys coucha后寄生虫负荷抑制约42%,为部分保护。
  • 免疫动物出现细胞增殖、TNF-α、IFN-γ、IL-1β、IL-4、NO释放、iNOS表达及特异性IgG、IgG1、IgG2b上调,多数肥大细胞脱颗粒。

核心结论

  • r-ClpBm免疫可部分保护Mastomys coucha抵抗马来布鲁丝虫感染,寄生虫负荷抑制约42%,作者认为其可进一步与其他保护性分子联合研究作为潜在丝虫鸡尾酒疫苗候选组分。

研究设计与样本

  • 研究克隆、表达并纯化了马来布鲁丝虫重组钙调蛋白(r-ClpBm),表征其二级结构,并在Mastomys coucha中评估免疫后感染攻击的保护效果。

主要发现

  • r-ClpBm为约45kDa蛋白,主要折叠为α-螺旋构象,与盘尾丝虫OV9M同源。
  • 钙调蛋白在微丝蚴、L3、L4、L5及成虫各生活史阶段均表达。
  • r-ClpBm免疫后Mastomys coucha寄生虫负荷抑制约42%,为部分保护。
  • 免疫动物细胞增殖、TNF-α、IFN-γ、IL-1β、IL-4、NO释放、iNOS表达及特异性IgG、IgG1、IgG2b上调,与寄生虫学结果相关。
  • r-ClpBm免疫导致多数肥大细胞脱颗粒,提示肥大细胞产物可能参与降低寄生虫存活。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the search for potential vaccine candidates for the control of human lymphatic filariasis, we recently identified calponin-like protein, that regulates actin/myosin interactions, in a proinflammatory fraction F8 (45.24-48.64kDa) of Brugia malayi adult worms. In the present study, the gene was cloned, expressed, and the recombinant Calponin of B. malayi (r-ClpBm) was prepared and characterized. r-ClpBm bears homology with OV9M of Onchocerca volvulus, a non-lymphatic filariid that causes loss of vision and cutaneous pathology. r-ClpBm was found to be a ∼45kDa protein that folds into a predominantly α-helix conformation. The protective efficacy of r-ClpBm against B. malayi infection in Mastomys coucha was investigated by assessing the course of microfilaraemia and adult worm burden in the host immunized with r-ClpBm and subsequently infected with infective third stage larvae (L3). Expression of the Calponin was detected in all life stages (microfilariae, L3, L4, L5 and adults) of the parasite and immunization with r-ClpBm partially protected M. coucha against establishment of infection as inferred by ∼42% inhibition in parasite burden. Upregulated cellular proliferation, TNF-α, IFN-γ, IL-1β, IL-4, nitric oxide (NO) release, expression of iNOS, and specific IgG, IgG1 and IgG2b in immunized animals correlated with parasitological findings. r-ClpBm immunization caused degranulation in majority of mast cells indicating possible involvement of mast cell products in reducing the parasite survival. It appears that complex mechanisms including Th1, Th2, NO and mast cells are involved in the clearance of infection. To the best of our knowledge this is the first report on cloning, expression of the gene and purification of r-ClpBm, determination of its secondary structure and its ability to partially prevent establishment of B. malayi infection. Thus, r-ClpBm may further be studied and developed in combination with other protective molecules of B. malayi as a component of potential filarial cocktail vaccine candidate.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Verma SK, Arora A, Murthy PK, et al. Recombinant Calponin of human filariid Brugia malayi: Secondary structure and immunoprophylactic potential. Vaccine. 2017. PMID: 28789852. doi:10.1016/j.vaccine.2017.07.105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。